Global Totally Implantable Venous Access Port (TIVAP) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
1 Market Overview
- 1.1 Product Overview and Scope of Totally Implantable Venous Access Port (TIVAP)
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Totally Implantable Venous Access Port (TIVAP) Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Titanium Chamber
- 1.3.3 Silicone Chamber
- 1.3.4 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Totally Implantable Venous Access Port (TIVAP) Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Intravenous Chemotherapy
- 1.4.3 Nutrition Support Therapy
- 1.4.4 Contrast Media Injection
- 1.5 Global Totally Implantable Venous Access Port (TIVAP) Market Size & Forecast
- 1.5.1 Global Totally Implantable Venous Access Port (TIVAP) Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Totally Implantable Venous Access Port (TIVAP) Sales Quantity (2018-2029)
- 1.5.3 Global Totally Implantable Venous Access Port (TIVAP) Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 B. Braun Medical
- 2.1.1 B. Braun Medical Details
- 2.1.2 B. Braun Medical Major Business
- 2.1.3 B. Braun Medical Totally Implantable Venous Access Port (TIVAP) Product and Services
- 2.1.4 B. Braun Medical Totally Implantable Venous Access Port (TIVAP) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 B. Braun Medical Recent Developments/Updates
- 2.2 BD (Becton, Dickinson and Company)
- 2.2.1 BD (Becton, Dickinson and Company) Details
- 2.2.2 BD (Becton, Dickinson and Company) Major Business
- 2.2.3 BD (Becton, Dickinson and Company) Totally Implantable Venous Access Port (TIVAP) Product and Services
- 2.2.4 BD (Becton, Dickinson and Company) Totally Implantable Venous Access Port (TIVAP) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 BD (Becton, Dickinson and Company) Recent Developments/Updates
- 2.3 Cook Medical
- 2.3.1 Cook Medical Details
- 2.3.2 Cook Medical Major Business
- 2.3.3 Cook Medical Totally Implantable Venous Access Port (TIVAP) Product and Services
- 2.3.4 Cook Medical Totally Implantable Venous Access Port (TIVAP) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Cook Medical Recent Developments/Updates
- 2.4 Smiths Medical
- 2.4.1 Smiths Medical Details
- 2.4.2 Smiths Medical Major Business
- 2.4.3 Smiths Medical Totally Implantable Venous Access Port (TIVAP) Product and Services
- 2.4.4 Smiths Medical Totally Implantable Venous Access Port (TIVAP) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Smiths Medical Recent Developments/Updates
- 2.5 Vygon
- 2.5.1 Vygon Details
- 2.5.2 Vygon Major Business
- 2.5.3 Vygon Totally Implantable Venous Access Port (TIVAP) Product and Services
- 2.5.4 Vygon Totally Implantable Venous Access Port (TIVAP) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Vygon Recent Developments/Updates
- 2.6 AngioDynamics
- 2.6.1 AngioDynamics Details
- 2.6.2 AngioDynamics Major Business
- 2.6.3 AngioDynamics Totally Implantable Venous Access Port (TIVAP) Product and Services
- 2.6.4 AngioDynamics Totally Implantable Venous Access Port (TIVAP) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 AngioDynamics Recent Developments/Updates
- 2.7 Teleflex Incorporated
- 2.7.1 Teleflex Incorporated Details
- 2.7.2 Teleflex Incorporated Major Business
- 2.7.3 Teleflex Incorporated Totally Implantable Venous Access Port (TIVAP) Product and Services
- 2.7.4 Teleflex Incorporated Totally Implantable Venous Access Port (TIVAP) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Teleflex Incorporated Recent Developments/Updates
- 2.8 PFM Medical
- 2.8.1 PFM Medical Details
- 2.8.2 PFM Medical Major Business
- 2.8.3 PFM Medical Totally Implantable Venous Access Port (TIVAP) Product and Services
- 2.8.4 PFM Medical Totally Implantable Venous Access Port (TIVAP) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 PFM Medical Recent Developments/Updates
- 2.9 Deltamed
- 2.9.1 Deltamed Details
- 2.9.2 Deltamed Major Business
- 2.9.3 Deltamed Totally Implantable Venous Access Port (TIVAP) Product and Services
- 2.9.4 Deltamed Totally Implantable Venous Access Port (TIVAP) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Deltamed Recent Developments/Updates
- 2.10 PakuMed
- 2.10.1 PakuMed Details
- 2.10.2 PakuMed Major Business
- 2.10.3 PakuMed Totally Implantable Venous Access Port (TIVAP) Product and Services
- 2.10.4 PakuMed Totally Implantable Venous Access Port (TIVAP) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 PakuMed Recent Developments/Updates
- 2.11 Sophysa
- 2.11.1 Sophysa Details
- 2.11.2 Sophysa Major Business
- 2.11.3 Sophysa Totally Implantable Venous Access Port (TIVAP) Product and Services
- 2.11.4 Sophysa Totally Implantable Venous Access Port (TIVAP) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 Sophysa Recent Developments/Updates
3 Competitive Environment: Totally Implantable Venous Access Port (TIVAP) by Manufacturer
- 3.1 Global Totally Implantable Venous Access Port (TIVAP) Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Totally Implantable Venous Access Port (TIVAP) Revenue by Manufacturer (2018-2023)
- 3.3 Global Totally Implantable Venous Access Port (TIVAP) Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Totally Implantable Venous Access Port (TIVAP) by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Totally Implantable Venous Access Port (TIVAP) Manufacturer Market Share in 2022
- 3.4.2 Top 6 Totally Implantable Venous Access Port (TIVAP) Manufacturer Market Share in 2022
- 3.5 Totally Implantable Venous Access Port (TIVAP) Market: Overall Company Footprint Analysis
- 3.5.1 Totally Implantable Venous Access Port (TIVAP) Market: Region Footprint
- 3.5.2 Totally Implantable Venous Access Port (TIVAP) Market: Company Product Type Footprint
- 3.5.3 Totally Implantable Venous Access Port (TIVAP) Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Totally Implantable Venous Access Port (TIVAP) Market Size by Region
- 4.1.1 Global Totally Implantable Venous Access Port (TIVAP) Sales Quantity by Region (2018-2029)
- 4.1.2 Global Totally Implantable Venous Access Port (TIVAP) Consumption Value by Region (2018-2029)
- 4.1.3 Global Totally Implantable Venous Access Port (TIVAP) Average Price by Region (2018-2029)
- 4.2 North America Totally Implantable Venous Access Port (TIVAP) Consumption Value (2018-2029)
- 4.3 Europe Totally Implantable Venous Access Port (TIVAP) Consumption Value (2018-2029)
- 4.4 Asia-Pacific Totally Implantable Venous Access Port (TIVAP) Consumption Value (2018-2029)
- 4.5 South America Totally Implantable Venous Access Port (TIVAP) Consumption Value (2018-2029)
- 4.6 Middle East and Africa Totally Implantable Venous Access Port (TIVAP) Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Totally Implantable Venous Access Port (TIVAP) Sales Quantity by Type (2018-2029)
- 5.2 Global Totally Implantable Venous Access Port (TIVAP) Consumption Value by Type (2018-2029)
- 5.3 Global Totally Implantable Venous Access Port (TIVAP) Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Totally Implantable Venous Access Port (TIVAP) Sales Quantity by Application (2018-2029)
- 6.2 Global Totally Implantable Venous Access Port (TIVAP) Consumption Value by Application (2018-2029)
- 6.3 Global Totally Implantable Venous Access Port (TIVAP) Average Price by Application (2018-2029)
7 North America
- 7.1 North America Totally Implantable Venous Access Port (TIVAP) Sales Quantity by Type (2018-2029)
- 7.2 North America Totally Implantable Venous Access Port (TIVAP) Sales Quantity by Application (2018-2029)
- 7.3 North America Totally Implantable Venous Access Port (TIVAP) Market Size by Country
- 7.3.1 North America Totally Implantable Venous Access Port (TIVAP) Sales Quantity by Country (2018-2029)
- 7.3.2 North America Totally Implantable Venous Access Port (TIVAP) Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Totally Implantable Venous Access Port (TIVAP) Sales Quantity by Type (2018-2029)
- 8.2 Europe Totally Implantable Venous Access Port (TIVAP) Sales Quantity by Application (2018-2029)
- 8.3 Europe Totally Implantable Venous Access Port (TIVAP) Market Size by Country
- 8.3.1 Europe Totally Implantable Venous Access Port (TIVAP) Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Totally Implantable Venous Access Port (TIVAP) Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Totally Implantable Venous Access Port (TIVAP) Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Totally Implantable Venous Access Port (TIVAP) Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Totally Implantable Venous Access Port (TIVAP) Market Size by Region
- 9.3.1 Asia-Pacific Totally Implantable Venous Access Port (TIVAP) Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Totally Implantable Venous Access Port (TIVAP) Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Totally Implantable Venous Access Port (TIVAP) Sales Quantity by Type (2018-2029)
- 10.2 South America Totally Implantable Venous Access Port (TIVAP) Sales Quantity by Application (2018-2029)
- 10.3 South America Totally Implantable Venous Access Port (TIVAP) Market Size by Country
- 10.3.1 South America Totally Implantable Venous Access Port (TIVAP) Sales Quantity by Country (2018-2029)
- 10.3.2 South America Totally Implantable Venous Access Port (TIVAP) Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Totally Implantable Venous Access Port (TIVAP) Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Totally Implantable Venous Access Port (TIVAP) Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Totally Implantable Venous Access Port (TIVAP) Market Size by Country
- 11.3.1 Middle East & Africa Totally Implantable Venous Access Port (TIVAP) Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Totally Implantable Venous Access Port (TIVAP) Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Totally Implantable Venous Access Port (TIVAP) Market Drivers
- 12.2 Totally Implantable Venous Access Port (TIVAP) Market Restraints
- 12.3 Totally Implantable Venous Access Port (TIVAP) Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Totally Implantable Venous Access Port (TIVAP) and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Totally Implantable Venous Access Port (TIVAP)
- 13.3 Totally Implantable Venous Access Port (TIVAP) Production Process
- 13.4 Totally Implantable Venous Access Port (TIVAP) Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Totally Implantable Venous Access Port (TIVAP) Typical Distributors
- 14.3 Totally Implantable Venous Access Port (TIVAP) Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Totally Implantable Venous Access Port (TIVAP) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
A Totally Implantable Venous Access Port (TIVAP) is a medical device designed for long-term intravenous (IV) therapy, providing a secure and convenient access point to the vascular system. Surgically implanted beneath the skin, usually in the chest area, the TIVAP consists of a reservoir and a catheter. The reservoir is accessed through the skin using a specialized needle, allowing healthcare professionals to administer medications, fluids, or draw blood without the need for repeated needle insertions. TIVAPs are commonly used in cancer treatment, chemotherapy, long-term antibiotic therapy, and other medical conditions requiring frequent or continuous intravenous interventions. This implantable device reduces the discomfort associated with repeated needle sticks and minimizes the risk of infection, providing a reliable and efficient means of delivering medical treatments directly into the bloodstream.
The Global Info Research report includes an overview of the development of the Totally Implantable Venous Access Port (TIVAP) industry chain, the market status of Intravenous Chemotherapy (Titanium Chamber, Silicone Chamber), Nutrition Support Therapy (Titanium Chamber, Silicone Chamber), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Totally Implantable Venous Access Port (TIVAP).
Regionally, the report analyzes the Totally Implantable Venous Access Port (TIVAP) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Totally Implantable Venous Access Port (TIVAP) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Totally Implantable Venous Access Port (TIVAP) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Totally Implantable Venous Access Port (TIVAP) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Titanium Chamber, Silicone Chamber).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Totally Implantable Venous Access Port (TIVAP) market.
Regional Analysis: The report involves examining the Totally Implantable Venous Access Port (TIVAP) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Totally Implantable Venous Access Port (TIVAP) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Totally Implantable Venous Access Port (TIVAP):
Company Analysis: Report covers individual Totally Implantable Venous Access Port (TIVAP) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Totally Implantable Venous Access Port (TIVAP) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Intravenous Chemotherapy, Nutrition Support Therapy).
Technology Analysis: Report covers specific technologies relevant to Totally Implantable Venous Access Port (TIVAP). It assesses the current state, advancements, and potential future developments in Totally Implantable Venous Access Port (TIVAP) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Totally Implantable Venous Access Port (TIVAP) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Totally Implantable Venous Access Port (TIVAP) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Titanium Chamber
Silicone Chamber
Others
Market segment by Application
Intravenous Chemotherapy
Nutrition Support Therapy
Contrast Media Injection
Major players covered
B. Braun Medical
BD (Becton, Dickinson and Company)
Cook Medical
Smiths Medical
Vygon
AngioDynamics
Teleflex Incorporated
PFM Medical
Deltamed
PakuMed
Sophysa
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Totally Implantable Venous Access Port (TIVAP) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Totally Implantable Venous Access Port (TIVAP), with price, sales, revenue and global market share of Totally Implantable Venous Access Port (TIVAP) from 2018 to 2023.
Chapter 3, the Totally Implantable Venous Access Port (TIVAP) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Totally Implantable Venous Access Port (TIVAP) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Totally Implantable Venous Access Port (TIVAP) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Totally Implantable Venous Access Port (TIVAP).
Chapter 14 and 15, to describe Totally Implantable Venous Access Port (TIVAP) sales channel, distributors, customers, research findings and conclusion.